Final Results from the NATALEE Trial: Ribociclib in Early Breast Cancer NATALEE Trial 5 Year Analysis at ESMO 2025: Adjuvant Ribociclib Plus NATALEE Trial eBC KISQALI (ribociclib) HCP Elisa Agostinetto: FDA has approved adjuvant ribociclib based on the Rationale and trial design of NATALEE: a Phase III trial of adjuvant Timothe Olivier: NATALEE trial, adjuvant ribociclib 21 days 28 for 3. Dress length measured from the bust line Size S: Dress length 53cm Size M: Dress length 54cm Size L: Dress length 55cm S: 84 62 90 M: 88 66 94 L: 92 70 98